Abstract
BackgroundChimeric antigen receptor (CAR) T cells are effective in B-cell malignancies. However, heterogeneous antigen expression and antigen loss remain important limitations of targeted immunotherapy in solid tumors. Therefore, targeting multiple...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have